Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

Himani Goyal, MD, takes glaucoma care to the next level by embracing advancements that extend beyond traditional treatment ...

We present a case of unilateral, secondary open-angle glaucoma due to an underlying diffuse iris melanoma. The patient was referred by his ophthalmologist with uncontrolled, elevated intraocular ...

[34] Three cohorts of glaucoma patients were defined according to the number of bottles (not medications) prescribed in month 1, and these patients were followed over a period of 12 months.

An eye doctor's main goal in the treatment of glaucoma is to lower eye pressure to a safe level in order to halt damage caused by the high-pressure levels. Treatment typically includes prescribing ...

Glaucoma is characterized by a silent onset, where the patient tends not to experience any symptoms in the early years of the disease. In the short term, when patients are treated for glaucoma ...

iDose TR implant shows sustained IOP reduction in open-angle glaucoma and ocular hypertension patients over 36 months. 70% of iDose TR patients maintained IOP control with the same or fewer ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The American Glaucoma Society and American Academy of Ophthalmology are warning eye doctors to be aware of potentially ...